BR0304956A - Combinação farmacêutica em uma nova forma farmacêutica útil na hipertensão arterial e na insuficiência coronariana crÈnica estável - Google Patents
Combinação farmacêutica em uma nova forma farmacêutica útil na hipertensão arterial e na insuficiência coronariana crÈnica estávelInfo
- Publication number
- BR0304956A BR0304956A BR0304956-6A BR0304956A BR0304956A BR 0304956 A BR0304956 A BR 0304956A BR 0304956 A BR0304956 A BR 0304956A BR 0304956 A BR0304956 A BR 0304956A
- Authority
- BR
- Brazil
- Prior art keywords
- hypertension
- coronary insufficiency
- form useful
- chronic stable
- stable coronary
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0304956-6A BR0304956A (pt) | 2003-12-09 | 2003-12-09 | Combinação farmacêutica em uma nova forma farmacêutica útil na hipertensão arterial e na insuficiência coronariana crÈnica estável |
ECSP045478 ECSP045478A (es) | 2003-12-09 | 2004-12-08 | Combinación farmacéutica en una nueva forma farmaceutica útil en la hipertensión arterial y en la insuficiencia coronaria estable. |
CO04123478A CO5650066A1 (es) | 2003-12-09 | 2004-12-09 | Combinacion farmaceutica en una nueva forma farmaceutica util en la hipertension arterial y en la insuficiencia coronaria estable |
PE2004001213A PE20050901A1 (es) | 2003-12-09 | 2004-12-09 | Combinacion de amlodipina y atenolol bajo la forma farmaceutica de capsula |
MXPA04012380 MXPA04012380A (es) | 2003-12-09 | 2004-12-09 | Combinacion farmaceutica en una nueva forma farmaceutica util en la hipertension arterial y en la insuficiencia coronaria cronica estable. |
ARP040104581 AR046876A1 (es) | 2003-12-09 | 2004-12-09 | Asociacion farmaceutica en una forma farmaceutica util en la hipertension arterial y en la insuficiencia coronaria cronica estable |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0304956-6A BR0304956A (pt) | 2003-12-09 | 2003-12-09 | Combinação farmacêutica em uma nova forma farmacêutica útil na hipertensão arterial e na insuficiência coronariana crÈnica estável |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0304956A true BR0304956A (pt) | 2005-11-08 |
Family
ID=35295191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0304956-6A BR0304956A (pt) | 2003-12-09 | 2003-12-09 | Combinação farmacêutica em uma nova forma farmacêutica útil na hipertensão arterial e na insuficiência coronariana crÈnica estável |
Country Status (6)
Country | Link |
---|---|
AR (1) | AR046876A1 (es) |
BR (1) | BR0304956A (es) |
CO (1) | CO5650066A1 (es) |
EC (1) | ECSP045478A (es) |
MX (1) | MXPA04012380A (es) |
PE (1) | PE20050901A1 (es) |
-
2003
- 2003-12-09 BR BR0304956-6A patent/BR0304956A/pt not_active IP Right Cessation
-
2004
- 2004-12-08 EC ECSP045478 patent/ECSP045478A/es unknown
- 2004-12-09 AR ARP040104581 patent/AR046876A1/es not_active Application Discontinuation
- 2004-12-09 PE PE2004001213A patent/PE20050901A1/es not_active Application Discontinuation
- 2004-12-09 MX MXPA04012380 patent/MXPA04012380A/es not_active Application Discontinuation
- 2004-12-09 CO CO04123478A patent/CO5650066A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CO5650066A1 (es) | 2006-06-30 |
AR046876A1 (es) | 2005-12-28 |
ECSP045478A (es) | 2006-09-18 |
MXPA04012380A (es) | 2005-10-19 |
PE20050901A1 (es) | 2005-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20051688D0 (no) | Farmasoytiske blandinger som har en modifisert baerer | |
NO20052739D0 (no) | CCR5-antagonister som medikamenter | |
NO20050115D0 (no) | Datamaskinnavigering | |
ATE485835T1 (de) | Antikörper enthaltende pharmazeutische lösungen | |
ATE223719T1 (de) | Schnellauflösende efavirenz-kapseln oder tabletten durch verwendung von super-zersetzern | |
CY1112582T1 (el) | Διαδερμικη χορηγηση φεντανυλης | |
DE60312049D1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff | |
EA200401515A1 (ru) | Новые фармацевтические композиции, содержащие флибансерин в полиморфной модификации а | |
FI20021310A (fi) | Jauhin | |
DE602004030346D1 (de) | Gelatinkapseln | |
PL1941263T3 (pl) | Optyczna półilościowa 100% kontrola napełniania kapsułek farmaceutycznych na maszynach do napełniania kapsułek | |
DK1694311T3 (da) | Tyggelige bløde kapsler indeholdende ugelatineret stivelse | |
DE60021609D1 (de) | Pharmazeutische Zusammensetzung enthaltend einen Metabolit von Buspirone | |
BR0304956A (pt) | Combinação farmacêutica em uma nova forma farmacêutica útil na hipertensão arterial e na insuficiência coronariana crÈnica estável | |
ATE332690T1 (de) | Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion | |
DE502004010073D1 (de) | Doppelseitiger tourbillon | |
DK1750765T3 (da) | Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel | |
ATE357220T1 (de) | Pharmazeutische zusammensetzung mit modifizierter freisetzung | |
ITRM20050521A1 (it) | Composizione a base di vitamine k e d per la prevenzione e il trattamento dell'osteoporosi. | |
DE60328787D1 (de) | Pharmazeutische salze von reboxetin | |
IS7581A (is) | Lyfjasamsetning | |
DE60217369D1 (de) | Pharmazeutische zusammensetzung enthaltend gamma-butyrobetain | |
BRPI0415428A (pt) | formulações terapêuticas | |
UY27824A1 (es) | Nueva formulación para la administración parenteral de crobenetina. | |
ITMI20030826A1 (it) | Composizione farmaceutica contenente interferone per il |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: BASEADO NO ART. 216 1 DA LPI, APRESENTE COPIA AUTENTICADA DA PROCURACAO PARA QUE ESTA SEJA ACEITA. |
|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: BIOSINTETICA FARMACEUTICA LTDA (BR/SP) Free format text: ALTERADO DE: LABORATORIOS BIOSINTETICA LTDA |
|
B25G | Requested change of headquarter approved |
Owner name: BIOSINTETICA FARMACEUTICA LTDA (BR/SP) Free format text: ALTERADA A SEDE DO TITULAR CONFORME REQUERIDO NA PETICAO NO 018050004541/SP DE 18/07/2005. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B25M | Entry on limitation or onus of patent assignment [chapter 25.13 patent gazette] |
Owner name: BIOSINTETICA FARMACEUTICA LTDA (BR/SP) Free format text: REF: PROC. INPI NO 52400031036/2012-78 E PROCESSO DE ARROLAMENTO DE BENS DA SECRETARIA DA RECEITA FEDERAL SP NO 16643.720002/2011-54 ANOTADO O ARROLAMENTO DO PEDIDO DE PATENTE EM EPIGRAFE, CONFORME DETERMINACAO DA SECRETARIA DA RECEITA FEDERAL DO ESTADO DE SAO PAULO, NOS TERMOS DO 5O, DO ART. 64 DA LEI NO 9.532/97. |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 9A E 10A ANUIDADES. |
|
B08I | Publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2257 DE 08/04/2014 POR TER SIDO INDEVIDA. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 9A, 10A, 11A, 12A, 13A, 14A, 15A E 16A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |